
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $3.1B | $3.7B | $3.2B | $2.7B | $2.8B | |
Revenue Growth (YoY) | 36.01% | 18.63% | -14.8% | -15.17% | 5.37% | |
Cost of Revenues | $1.3B | $1.5B | $1.3B | $1.1B | $1.2B | |
Gross Profit | $1.8B | $2.2B | $1.9B | $1.5B | $1.6B | |
Gross Profit Margin | 57.21% | 59.59% | 59.18% | 57.42% | 58.48% | |
R&D Expenses | $375M | $427.6M | $440.6M | $418.1M | $460.9M | |
Selling, General & Admin | $464.8M | $547.6M | $558.1M | $577.3M | $617M | |
Other Inc / (Exp) | $4M | -$33.9M | -$11.4M | -$20.3M | $35.7M | |
Operating Expenses | $870.5M | $996.6M | $1B | $1B | $1.1B | |
Operating Income | $915.2M | $1.2B | $849.1M | $522.3M | $552.2M | |
Net Interest Expenses | $18.2M | $15.2M | -- | -- | -- | |
EBT. Incl. Unusual Items | $901M | $1.2B | $840.4M | $525.6M | $609.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $116.9M | $146.4M | $124.9M | $76.8M | $59.5M | |
Net Income to Company | $784.1M | $1B | $715.5M | $448.8M | $542.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $784.1M | $1B | $715.5M | $448.8M | $542.4M | |
Basic EPS (Cont. Ops) | $4.72 | $6.15 | $4.52 | $2.91 | $3.41 | |
Diluted EPS (Cont. Ops) | $4.28 | $5.53 | $4.22 | $2.73 | $3.32 | |
Weighted Average Basic Share | $166.1M | $165M | $158.4M | $154.3M | $159.1M | |
Weighted Average Diluted Share | $183M | $183.6M | $169.7M | $164.3M | $163.3M | |
EBITDA | $1.1B | $1.3B | $954.8M | $640.3M | $732.4M | |
EBIT | $925.2M | $1.2B | $844.1M | $529.4M | $612.7M | |
Revenue (Reported) | $3.1B | $3.7B | $3.2B | $2.7B | $2.8B | |
Operating Income (Reported) | $915.2M | $1.2B | $849.1M | $522.3M | $552.2M | |
Operating Income (Adjusted) | $925.2M | $1.2B | $844.1M | $529.4M | $612.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $781.6M | $755.4M | $617.5M | $599.8M | $685.7M | |
Revenue Growth (YoY) | 10.97% | -3.36% | -18.25% | -2.87% | 14.32% | |
Cost of Revenues | $320M | $300.4M | $261.1M | $260.5M | $270.3M | |
Gross Profit | $461.6M | $454.9M | $356.4M | $339.3M | $415.3M | |
Gross Profit Margin | 59.06% | 60.23% | 57.72% | 56.56% | 60.57% | |
R&D Expenses | $100.4M | $108.1M | $105.8M | $103.2M | $118.2M | |
Selling, General & Admin | $129.8M | $140.2M | $151M | $149.2M | $157.3M | |
Other Inc / (Exp) | $3.3M | -$20.9M | -$2.1M | -$16.5M | -$20.6M | |
Operating Expenses | $235.7M | $253.4M | $261.5M | $257.1M | $280M | |
Operating Income | $225.9M | $201.6M | $94.9M | $82.2M | $135.3M | |
Net Interest Expenses | $5.2M | $309K | -- | -- | $2.3M | |
EBT. Incl. Unusual Items | $224M | $180.4M | $97.1M | $72.9M | $119M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $18.5M | $18.4M | $13.6M | $8.7M | $14.5M | |
Net Income to Company | $205.5M | $161.9M | $83.5M | $64.2M | $98.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $205.5M | $161.9M | $83.5M | $64.2M | $98.9M | |
Basic EPS (Cont. Ops) | $1.23 | $1.00 | $0.54 | $0.42 | $0.61 | |
Diluted EPS (Cont. Ops) | $1.09 | $0.92 | $0.50 | $0.40 | $0.61 | |
Weighted Average Basic Share | $166.5M | $162M | $155.9M | $153M | $161.5M | |
Weighted Average Diluted Share | $187.7M | $175.6M | $166.3M | $162.3M | $162M | |
EBITDA | $263.7M | $209.1M | $125.7M | $101.7M | $150.1M | |
EBIT | $230M | $181.4M | $98.1M | $73.6M | $119.8M | |
Revenue (Reported) | $781.6M | $755.4M | $617.5M | $599.8M | $685.7M | |
Operating Income (Reported) | $225.9M | $201.6M | $94.9M | $82.2M | $135.3M | |
Operating Income (Adjusted) | $230M | $181.4M | $98.1M | $73.6M | $119.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.2B | $3.7B | $3B | $2.7B | $2.9B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.4B | $1.5B | $1.2B | $1.1B | $1.2B | |
Gross Profit | $1.8B | $2.2B | $1.8B | $1.5B | $1.7B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $390.2M | $435.3M | $438.2M | $415.5M | $475.9M | |
Selling, General & Admin | $483.2M | $557.9M | $568.9M | $575.5M | $625.1M | |
Other Inc / (Exp) | $6.6M | -$58.1M | $7.4M | -$34.7M | $31.6M | |
Operating Expenses | $899.8M | $1B | $1B | $1B | $1.1B | |
Operating Income | $942M | $1.2B | $742.5M | $509.6M | $605.4M | |
Net Interest Expenses | $20.6M | $10.3M | -- | -- | -- | |
EBT. Incl. Unusual Items | $927.9M | $1.1B | $757.1M | $501.4M | $655.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $114.5M | $146.3M | $120M | $72M | $65.3M | |
Net Income to Company | $813.5M | $971M | $637.1M | $429.4M | $577.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $813.5M | $971M | $637.1M | $429.4M | $577.1M | |
Basic EPS (Cont. Ops) | $4.89 | $5.95 | $4.06 | $2.80 | $3.58 | |
Diluted EPS (Cont. Ops) | $4.40 | $5.38 | $3.80 | $2.63 | $3.54 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $1.1B | $1.2B | $871.3M | $616.3M | $780.9M | |
EBIT | $952.6M | $1.1B | $760.8M | $504.9M | $658.9M | |
Revenue (Reported) | $3.2B | $3.7B | $3B | $2.7B | $2.9B | |
Operating Income (Reported) | $942M | $1.2B | $742.5M | $509.6M | $605.4M | |
Operating Income (Adjusted) | $952.6M | $1.1B | $760.8M | $504.9M | $658.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $781.6M | $755.4M | $617.5M | $599.8M | $685.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $320M | $300.4M | $261.1M | $260.5M | $270.3M | |
Gross Profit | $461.6M | $454.9M | $356.4M | $339.3M | $415.3M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $100.4M | $108.1M | $105.8M | $103.2M | $118.2M | |
Selling, General & Admin | $129.8M | $140.2M | $151M | $149.2M | $157.3M | |
Other Inc / (Exp) | $3.3M | -$20.9M | -$2.1M | -$16.5M | -$20.6M | |
Operating Expenses | $235.7M | $253.4M | $261.5M | $257.1M | $280M | |
Operating Income | $225.9M | $201.6M | $94.9M | $82.2M | $135.3M | |
Net Interest Expenses | $5.2M | $309K | -- | -- | $2.3M | |
EBT. Incl. Unusual Items | $224M | $180.4M | $97.1M | $72.9M | $119M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $18.5M | $18.4M | $13.6M | $8.7M | $14.5M | |
Net Income to Company | $205.5M | $161.9M | $83.5M | $64.2M | $98.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $205.5M | $161.9M | $83.5M | $64.2M | $98.9M | |
Basic EPS (Cont. Ops) | $1.23 | $1.00 | $0.54 | $0.42 | $0.61 | |
Diluted EPS (Cont. Ops) | $1.09 | $0.92 | $0.50 | $0.40 | $0.61 | |
Weighted Average Basic Share | $166.5M | $162M | $155.9M | $153M | $161.5M | |
Weighted Average Diluted Share | $187.7M | $175.6M | $166.3M | $162.3M | $162M | |
EBITDA | $263.7M | $209.1M | $125.7M | $101.7M | $150.1M | |
EBIT | $230M | $181.4M | $98.1M | $73.6M | $119.8M | |
Revenue (Reported) | $781.6M | $755.4M | $617.5M | $599.8M | $685.7M | |
Operating Income (Reported) | $225.9M | $201.6M | $94.9M | $82.2M | $135.3M | |
Operating Income (Adjusted) | $230M | $181.4M | $98.1M | $73.6M | $119.8M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $914.1M | $1.1B | $854.8M | $757.6M | $553.4M | |
Short Term Investments | $522.3M | $244.2M | $39.6M | $62.2M | $46.3M | |
Accounts Receivable, Net | $497.5M | $550.7M | $491.1M | $422.1M | $471.4M | |
Inventory | $222.2M | $243.3M | $325M | $310M | $298.5M | |
Prepaid Expenses | -- | $406.3M | $533M | $549M | $429.1M | |
Other Current Assets | $259.3M | $9.5M | $14.4M | $38M | $17.7M | |
Total Current Assets | $2.4B | $2.6B | $2.3B | $2.2B | $1.8B | |
Property Plant And Equipment | $449.4M | $456M | $492.4M | $518.9M | $578.4M | |
Long-Term Investments | $118M | $133.9M | $110.8M | $117.4M | $618.6M | |
Goodwill | $453.9M | $426M | $403.2M | $415.7M | $395.4M | |
Other Intangibles | $100.9M | $75.6M | $53.5M | $35.4M | $15.9M | |
Other Long-Term Assets | $9.4M | $24.1M | $28.9M | $50.1M | $49.6M | |
Total Assets | $3.7B | $3.8B | $3.5B | $3.5B | $3.7B | |
Accounts Payable | $133.7M | $153.1M | $139.7M | $180.1M | $134.8M | |
Accrued Expenses | $77.6M | $124.2M | $112.3M | $114.7M | $90.8M | |
Current Portion Of Long-Term Debt | $33.3M | $19.2M | $50.1M | -- | -- | |
Current Portion Of Capital Lease Obligations | $20.6M | $20M | $18.6M | $17.5M | $18.7M | |
Other Current Liabilities | -- | -- | -- | $7.4M | -- | |
Total Current Liabilities | $700.9M | $805.1M | $746.3M | $660M | $624.6M | |
Long-Term Debt | $376.8M | $89.2M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.4B | $1.2B | $1B | $960.9M | $889.4M | |
Common Stock | $20.8M | $20.3M | $19.5M | $19.1M | $20.2M | |
Other Common Equity Adj | $33.5M | $3.7M | -$49.9M | -$27M | -$81.2M | |
Common Equity | $2.2B | $2.6B | $2.5B | $2.5B | $2.8B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.2B | $2.6B | $2.5B | $2.5B | $2.8B | |
Total Liabilities and Equity | $3.7B | $3.8B | $3.5B | $3.5B | $3.7B | |
Cash and Short Terms | $1.4B | $1.4B | $894.4M | $819.7M | $599.7M | |
Total Debt | $410.1M | $108.4M | $50.1M | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $831.1M | $794.6M | $649.2M | $707.4M | $475.6M | |
Short Term Investments | $478.3M | $282M | $92.9M | $41.3M | $32.1M | |
Accounts Receivable, Net | $581.5M | $546.9M | $455.3M | $426.3M | $460.4M | |
Inventory | $262.5M | $259.3M | $352.1M | $314.2M | $345.1M | |
Prepaid Expenses | -- | -- | -- | $537.6M | $423.7M | |
Other Current Assets | $347.7M | $491.5M | $562.5M | $16.1M | $18.6M | |
Total Current Assets | $2.5B | $2.4B | $2.1B | $2.1B | $1.8B | |
Property Plant And Equipment | $454M | $467.2M | $507.3M | $531.9M | $604.6M | |
Long-Term Investments | $115.6M | $126.1M | $116.9M | $121.9M | $623.4M | |
Goodwill | $437.6M | $419.9M | $409.8M | $407.6M | $409.3M | |
Other Intangibles | $92.9M | $69.8M | $49.2M | $30.2M | $18M | |
Other Long-Term Assets | $8.9M | $23.5M | $27.9M | $56.6M | $51.8M | |
Total Assets | $3.7B | $3.6B | $3.4B | $3.4B | $3.7B | |
Accounts Payable | $177.5M | $156.5M | $142.4M | $153.9M | $187M | |
Accrued Expenses | $105.2M | $118.3M | $114.7M | $101.3M | $100.1M | |
Current Portion Of Long-Term Debt | $11.1M | $20.5M | $35.1M | -- | -- | |
Current Portion Of Capital Lease Obligations | $19.7M | $18.5M | $20M | $17.4M | $18.3M | |
Other Current Liabilities | -- | -- | -- | $4.7M | -- | |
Total Current Liabilities | $686.8M | $712.2M | $628.1M | $554.4M | $649.1M | |
Long-Term Debt | $356.9M | $75.4M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.4B | $1.1B | $933.9M | $852.9M | $908.3M | |
Common Stock | $20.8M | $20.1M | $19.4M | $19.2M | $20.1M | |
Other Common Equity Adj | $8.7M | -$19.5M | -$36.5M | -$39.7M | -$42M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $2.3B | $2.5B | $2.4B | $2.6B | $2.8B | |
Total Liabilities and Equity | $3.7B | $3.6B | $3.4B | $3.4B | $3.7B | |
Cash and Short Terms | $1.3B | $1.1B | $742.1M | $748.7M | $507.8M | |
Total Debt | $367.9M | $95.9M | $35.1M | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $784.1M | $1B | $715.5M | $448.8M | $542.4M | |
Depreciation & Amoritzation | $126.7M | $125.5M | $110.7M | $110.9M | $119.7M | |
Stock-Based Compensation | $44.9M | $45.6M | $48.2M | $57.7M | $60.1M | |
Change in Accounts Receivable | -$129.5M | -$57.8M | $50.6M | $71M | -$52.7M | |
Change in Inventories | -$8.4M | $6.5M | -$80.8M | $5.3M | $8.7M | |
Cash From Operations | $868.9M | $1.1B | $577.9M | $585.2M | $672.2M | |
Capital Expenditures | $185M | $132.5M | $163.2M | $159.6M | $198.1M | |
Cash Acquisitions | -- | -- | -- | -- | -$441.7M | |
Cash From Investing | -$569.8M | $120.4M | $43.8M | -$179.6M | -$622.3M | |
Dividends Paid (Ex Special Dividend) | -$66.5M | -$66M | -$69.7M | -$67.9M | -$76.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | $185M | |
Long-Term Debt Repaid | -- | -$343M | -$66.8M | -$50.3M | -$185M | |
Repurchase of Common Stock | -$88.5M | -$600M | -$752.1M | -$397.2M | -$198.6M | |
Other Financing Activities | -$8.9M | -- | -- | -- | -- | |
Cash From Financing | -$158.3M | -$1B | -$893M | -$501.9M | -$251.8M | |
Beginning Cash (CF) | $773.9M | $914.1M | $1.1B | $854.8M | $757.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $140.9M | $210.1M | -$271.3M | -$96.3M | -$201.9M | |
Ending Cash (CF) | $914.1M | $1.1B | $854.8M | $757.6M | $553.4M | |
Levered Free Cash Flow | $684M | $965.9M | $414.7M | $425.6M | $474.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $205.5M | $161.9M | $83.5M | $64.2M | $98.9M | |
Depreciation & Amoritzation | $33.7M | $27.7M | $27.6M | $28.1M | $30.3M | |
Stock-Based Compensation | $12.2M | $12.9M | $18.9M | $15.8M | $15.2M | |
Change in Accounts Receivable | -$87.5M | $208K | $37.2M | -$8.1M | $13.1M | |
Change in Inventories | -$35.9M | -$9.5M | -$23.7M | -$6.9M | -$31M | |
Cash From Operations | $38.1M | $7.5M | $19.3M | $7.3M | $161.6M | |
Capital Expenditures | $39.3M | $44M | $41.4M | $44M | $64M | |
Cash Acquisitions | -- | -- | -- | -- | -$20M | |
Cash From Investing | $4.7M | -$82.7M | -$94.9M | -$24M | -$61.8M | |
Dividends Paid (Ex Special Dividend) | -$16.7M | -$17.9M | -$17.2M | -$18.4M | -$19.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$51.3M | -$20.7M | -$15.2M | -- | -- | |
Repurchase of Common Stock | -$45.2M | -$201.5M | -$93.3M | -$22.1M | -$157.5M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$126.7M | -$254.6M | -$129.5M | -$36.7M | -$176.8M | |
Beginning Cash (CF) | $914.1M | $1.1B | $854.8M | $757.6M | $553.4M | |
Foreign Exchange Rate Adjustment | $883K | $2.3M | -$537K | $3.2M | -$771K | |
Additions / Reductions | -$83.9M | -$329.9M | -$205M | -$53.4M | -$77M | |
Ending Cash (CF) | $831.1M | $794.6M | $649.2M | $707.4M | $475.6M | |
Levered Free Cash Flow | -$1.1M | -$36.5M | -$22.1M | -$36.7M | $97.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $813.5M | $971M | $637.1M | $429.4M | $577.1M | |
Depreciation & Amoritzation | $128.6M | $119.5M | $110.5M | $111.4M | $121.9M | |
Stock-Based Compensation | $46.7M | $46.3M | $54.2M | $54.6M | $59.6M | |
Change in Accounts Receivable | -$90.2M | $29.9M | $87.6M | $25.7M | -$31.6M | |
Change in Inventories | -$60.1M | $32.9M | -$95M | $22.1M | -$15.4M | |
Cash From Operations | $864M | $1.1B | $589.8M | $573.2M | $826.5M | |
Capital Expenditures | $187.5M | $137.2M | $160.7M | $162.2M | $218.1M | |
Cash Acquisitions | -$149K | -- | -- | -- | -$461.7M | |
Cash From Investing | -$454.9M | $33M | $31.6M | -$108.8M | -$660.1M | |
Dividends Paid (Ex Special Dividend) | -$66.5M | -$67.2M | -$69M | -$69.1M | -$77.5M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$51.3M | -$312.4M | -$61.2M | -$35.1M | -- | |
Repurchase of Common Stock | -$54.6M | -$756.3M | -$643.9M | -$326.1M | -$333.9M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$171.1M | -$1.1B | -$767.9M | -$409.1M | -$391.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $238M | -$35.9M | -$146.5M | $55.3M | -$225.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $676.4M | $930.5M | $429.1M | $411M | $608.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $205.5M | $161.9M | $83.5M | $64.2M | $98.9M | |
Depreciation & Amoritzation | $33.7M | $27.7M | $27.6M | $28.1M | $30.3M | |
Stock-Based Compensation | $12.2M | $12.9M | $18.9M | $15.8M | $15.2M | |
Change in Accounts Receivable | -$87.5M | $208K | $37.2M | -$8.1M | $13.1M | |
Change in Inventories | -$35.9M | -$9.5M | -$23.7M | -$6.9M | -$31M | |
Cash From Operations | $38.1M | $7.5M | $19.3M | $7.3M | $161.6M | |
Capital Expenditures | $39.3M | $44M | $41.4M | $44M | $64M | |
Cash Acquisitions | -- | -- | -- | -- | -$20M | |
Cash From Investing | $4.7M | -$82.7M | -$94.9M | -$24M | -$61.8M | |
Dividends Paid (Ex Special Dividend) | -$16.7M | -$17.9M | -$17.2M | -$18.4M | -$19.4M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$51.3M | -$20.7M | -$15.2M | -- | -- | |
Repurchase of Common Stock | -$45.2M | -$201.5M | -$93.3M | -$22.1M | -$157.5M | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -$126.7M | -$254.6M | -$129.5M | -$36.7M | -$176.8M | |
Beginning Cash (CF) | $914.1M | $1.1B | $854.8M | $757.6M | $553.4M | |
Foreign Exchange Rate Adjustment | $883K | $2.3M | -$537K | $3.2M | -$771K | |
Additions / Reductions | -$83.9M | -$329.9M | -$205M | -$53.4M | -$77M | |
Ending Cash (CF) | $831.1M | $794.6M | $649.2M | $707.4M | $475.6M | |
Levered Free Cash Flow | -$1.1M | -$36.5M | -$22.1M | -$36.7M | $97.6M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.